Document is current
Any future updates will be listed below
-
Authors
Teni, Fitsum Sebsibe http://orcid.org/0000-0002-6182-499X
Burström, Kristina
Devlin, Nancy
Parkin, David
Rolfson, Ola
,
Abbott, Allan
Ekström, Magnus
Forssblad, Magnus
Fritzell, Peter
Jonsson, Åsa
Landén, Mikael
Möller, Michael
Regardt, Malin
Rosengren, Björn
Schmitt-Egenolf, Marcus
Vinblad, Johanna
W-Dahl, Annette
-
Funding
Funding for this research was provided by:
The EuroQol Research Foundation (2016480)
Region Stockholm (4-3464/2018)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 20 December 2022
Accepted: 22 March 2023
First Online: 10 April 2023
Declarations
:
: The study received ethical approval from the Regional Ethics Review Board in Gothenburg for the data from the NQRs (#1185–18/2019–00812 and #2020–04369) and from the Swedish Ethical Review Authority (#2020–03090) for the general population data.
: Not applicable.
: KB, ND and DP are members of the EuroQol Group. KB reports grants from EuroQol Research Foundation, grants from Region Stockholm, during the conduct of the study; personal fees from Region Stockholm, outside the submitted work. ML reports personal fees from Lundbeck pharmaceuticals, outside the submitted work. OR reports institutional compensation for educational consultancy from Link Sweden; institutional compensation for research consultancy from Pfizer, outside the submitted work. AA, ME, MF, PF, ÅJ, MM, MR, BR, MSE, FST, AWD and JV declare no competing interests.
